Bursitis — Patent Landscape

Aggregated US Orange Book patent estate across every approved drug for bursitis. 35 active patents protecting 3 drugs from 1+ originators. First major cliff: 2032. Daily refresh.

3
Approved drugs
35
Active US patents
55/100
Avg vulnerability
—
Annual revenue covered

Originators in Bursitis

Companies holding active patents on drugs approved for this indication. Click through to each company's full patent dashboard.

Generic (originally Merck/Upjohn) 29 patents

Cliff calendar — next 15 years

Patent expiries per year across all drugs treating bursitis. Each bar = one year. Y-axis scaled to peak year (8 patents).

2
27
1
28
8
30
5
32
4
33
7
34
1
36
3
37
1
39
1
41

Approved drugs ranked by patent estate

Drug Originator Active patents Avg vuln Revenue First cliff
Decadron
dexamethasone
 Generic (originally Merck) 15 46 — 2027-12-19
Cortef
hydrocortisone
 Generic (originally Merck/Upjohn) 14 64 — 2032-11-19
Indocin Sr
INDOMETHACIN
 — 6 56 — 2030-04-23

Most attackable patents

Highest vulnerability scores in the indication — paragraph IV / IPR / design-around candidates.

Patent Drug Type Vuln Expiry
11904046 Cortef method of use 75 2043-02-23
12133914 Cortef method of use 75 2043-02-23
9089471 Indocin Sr method of use 68 2030-04-23
9089471 Indocin Sr method of use 68 2030-04-23
8101582 Decadron method of use 63 2027-12-19
7795316 Decadron method of use 63 2028-08-03
9717740 Cortef method of use 62 2032-11-19
9717740 Cortef method of use 62 2032-11-19
9717740 Cortef method of use 62 2032-11-19
9717740 Cortef method of use 62 2032-11-19

Strongest defences

Lowest vulnerability scores — pillars of the indication's IP fortress.

Patent Drug Type Vuln Expiry
10537585 Decadron formulation 25 2037-12-18
10159683 Decadron formulation 25 2034-05-23
10799642 Decadron formulation 31 2032-05-11
8409606 Decadron formulation 31 2030-05-14
8450287 Decadron formulation 38 2027-12-19
10022502 Decadron method of use 45 2034-06-22
10028965 Decadron method of use 45 2034-05-23
8992982 Indocin Sr formulation 48 2030-04-23
8992982 Indocin Sr formulation 48 2030-04-23
8563027 Decadron method of use 51 2030-02-12

Related